Osteoarthritis
Conditions
Interventions
This is a clinical trial of intervention, prospective, controlled, randomized, blinded for the evaluator, comparing the effect of intra-articular injection of corticosteroid versus neurolysis of the a
Sponsors
Gilson Carone Neto
Hospital do Servidor Público Estadual de São Paulo
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Male and female patients; over 18 years old; with pain in the acromioclavicular joint (for more than a month); with moderate or severe chronic joint pain (VAS equal to or greater than 4).
Exclusion criteria
Exclusion criteria: Patients with contraindications to the procedure: blood dyscrasia; refusal of the procedure; infection at the puncture site; patients with any other shoulder dysfunction that may confound the diagnosis such as advanced osteoarthritis of the glenohumeral joint, or adhesive capsulitis; patients with cognitive impairment or psychiatric disorder; allergic to lidocaine, methylprednisolone and phenol; pregnant women; patients with complete loss of joint space on ultrasound examination.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the efficacy of neurolysis with 5% phenol in the treatment of pain in patients with acromioclavicular joint pain compared with intra-articular corticosteroid injection. | — |
Secondary
| Measure | Time frame |
|---|---|
| To verify if there is superiority of neurolysis over intra-articular corticosteroid injection to improve joint pain;Assess pain over a 6-month period, through the numerical verbal pain scale and ASES (American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form) questionnaire: pre-procedure, 1 hour after the procedure, after 1 week, 1 month, 3 and 6 months; | — |
Countries
Brazil
Contacts
Public ContactGilson Neto
Hospital do Servidor Público Estadual de São Paulo
Outcome results
None listed